Circulating tumor cells as a potential biomarker in diagnosis of lung cancer: a systematic review and meta‐analysis

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Clinical Respiratory Journal

• Publication date

  2018-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/crj.12573PMID 27778482
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic significance of circulating tumor cells in esophageal carcinoma: a meta-analysis

  2016cited by this paper
• Aptamer-Mediated Transparent-Biocompatible Nanostructured Surfaces for Hepotocellular Circulating Tumor Cells Enrichment

  2016cited by this paper
• Lung Cancer Incidence Trends by Gender, Race and Histology in the United States, 1973–2010

  2015cited by this paper
• Occupational exposure to wood dust and risk of lung cancer in two population-based case–control studies in Montreal, Canada

  2015cited by this paper
• Chronic Obstructive Pulmonary Disease and Subsequent Overall and Lung Cancer Mortality in Low-Income Adults

  2015cited by this paper
• Circulating Tumor Cells in Diagnosing Lung Cancer: Clinical and Morphologic Analysis.

  2015cited by this paper
• Comparative effectiveness of surgery and radiosurgery for stage I non–small cell lung cancer

  2015cited by this paper
• Incidence and survival from lung cancer in Greenland is comparable to survival in the Nordic countries.

  2015cited by this paper
• Circulating tumor cells as trigger to hematogenous spreads and potential biomarkers to predict the prognosis in ovarian cancer

  2015cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• Cancer statistics, 2015

  2015cited by this paper
• Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?

  2014cited by this paper
• Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluorescence in situ hybridization.

  2014cited by this paper
• Clinical results of microfluidic antibody-independent peripheral blood circulating tumor cell capture for the diagnosis of lung cancer.

  2014cited by this paper
• Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device.

  2014cited by this paper
• Effect of circulating tumor cells combined with negative enrichment and CD45-FISH identification in diagnosis, therapy monitoring and prognosis of primary lung cancer

  2014cited by this paper
• Prognostic role of circulating tumor cells and disseminated tumor cells in patients with prostate cancer: a systematic review and meta-analysis

  2014cited by this paper
• Detection of circulating tumor cells from lung cancer patients in the era of targeted therapy: promises, drawbacks and pitfalls.

  2014cited by this paper
• Quantification of Rare Circulating Tumor Cells in Non-Small Cell Lung Cancer by Ligand-Targeted PCR

  2013cited by this paper
• Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer.

  2013cited by this paper
• Optical diagnosis for lung cancer using multiphoton imaging.

  2013cited by this paper
• Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer.

  2013cited by this paper
• Prognostic Significance of Circulating Tumor Cells in Non-Small-Cell Lung Cancer Patients: A Meta-Analysis

  2013cited by this paper
• Lung cancer circulating tumor cells isolated by the EpCAM-independent enrichment strategy correlate with Cytokeratin 19-derived CYFRA21-1 and pathological staging.

  2013cited by this paper
• Circulating Tumor Cells in Lung Cancer

  2012cited by this paper
• Global cancer statistics

  2011cited by this paper
• Diagnostic values of SCC, CEA, Cyfra21-1 and NSE for lung cancer in patients with suspicious pulmonary masses: A single center analysis

  2011cited by this paper
• Circulating Tumor Cell as a Diagnostic Marker in Primary Lung Cancer

  2009cited by this paper
• Advances in chemotherapy for non-small cell lung cancer.

  2008cited by this paper
• Application of summary receiver operating characteristics (sROC) analysis to diagnostic clinical testing.

  2007cited by this paper
• Bmc Medical Research Methodology Open Access Intra-cluster Correlation Coefficients in Adults with Diabetes in Primary Care Practices: the Vermont Diabetes Information System Field Survey

  2006cited by this paper
• Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival

  2006cited by this paper
• Advances in chemotherapy of non-small cell lung cancer.

  2006cited by this paper
• Bmc Medical Research Methodology Open Access Motor Function in Parkinson's Disease and Supranuclear Palsy: Simultaneous Factor Analysis of a Clinical Scale in Several Populations

  2006influential reference
• A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy.

  2005cited by this paper
• Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests.

  2005cited by this paper
• Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris) for the treatment of severe sepsis in adults: a systematic review and economic evaluation.

  2005cited by this paper
• Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases

  2004cited by this paper
• Bmc Medical Research Methodology Open Access Proportional Odds Ratio Model for Comparison of Diagnostic Tests in Meta-analysis

  2004cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data

  2002cited by this paper
• Cancer statistics

  1989cited by this paper

• Levels of active forms of MMP-1, MMP-2, and MMP-9 as independent prognostic factors for differentiating the stage and type of lung cancer (SCLC and NSCLC)

  2024cites this paper
• Different Liquid Biopsies for the Management of Non-Small Cell Lung Cancer in the Mutational Oncology Era

  2023cites this paper
• Potential Cancer Biomarkers

  2022cites this paper
• Circulating tumor cells with epithelial-mesenchymal transition markers as potential biomarkers for the diagnosis of lung cancer

  2021cites this paper
• Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer

  2021cites this paper
• The clinical application value of miR-1269 as an unfavorable prognostic indicator of lung cancer.

  2021cites this paper
• Distribution and Clinical Analysis of EpCAM+/Vimentin+ Circulating Tumor Cells in High-Risk Population and Cancer Patients

  2021cites this paper
• Circulating tumor cells in bladder cancer: a new horizon of liquid biopsy for precision medicine

  2021cites this paper
• Mesothelioma Biomarkers: A Review Highlighting Contributions from the Early Detection Research Network

  2020cites this paper
• Optimization of the Enrichment of Circulating Tumor Cells for Downstream Phenotypic Analysis in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1 Immunotherapy

  2020cites this paper
• Plasma Epstein-Barr Virus-Deoxyribonucleic Acid Copy Number Predicts Disease Progression in Stage I–III Pulmonary Lymphoepithelioma-Like Carcinoma

  2020cites this paper
• Mesothelioma Biomarkers: Discovery in Search of Validation.

  2020cites this paper
• Comparison of value of biomarkers in diagnosing lung cancer

  2019cites this paper
• Molecular characterization of circulating tumor cells in lung cancer: moving beyond enumeration

  2017cites this paper
• Using the New CellCollector to Capture Circulating Tumor Cells from Blood in Different Groups of Pulmonary Disease: A Cohort Study

  2017cites this paper